Wilshire Pharmaceuticals utilizes global partnerships and networks for the research, development and manufacturing of key generic products for the U.S. market. These extensive relationships have resulted in a pipeline and product development strategy surrounding multiple therapeutic categories and indications.

Management Team

Photo of Scott White

Scott White

Mr. Scott White, President of Wilshire Pharmaceuticals, joined the company in late 2011.

Prior to joining Wilshire, Mr. White held the position of CEO at Aurobindo Pharmaceuticals, USA where he was successful in growing the business from a start-up to what is now a globally recognized industry leader. Mr. White has also held key leadership positions at Ivax Laboratories and Bedford Laboratories.

Having held numerous leadership roles and responsibilities throughout his career, Mr. White has extensive knowledge in all aspects of the generic pharmaceutical business, including Sales and Marketing, Distribution, Manufacturing, Research and Development, Business Development and Executive Management.

The industry leading experience and knowledge of Wilshire Pharmaceuticals management team combined with the financial support of a group of distinguished industry veterans and private equity funding, has created the foundation for a successful and sustainable generic pharmaceutical company.